News & Analysis on Clinical Trial Services & Contract Research And Development
Multinational excipient-makers will drive US interest in EXCiPACT, the industry-led certification scheme says as a UK Colorcon plant becomes the eighteenth site to receive accreditation.
As Big Pharma and biotech companies continue to outsource more of their work, one of the leaders in the preclinical and discovery space – Charles River Laboratories – is seeing more strategic relationships with both large and small clients, CEO James...
Tweets warning of Ebola were read by millions before the outbreak was acknowledged say researchers who think the network could be used as an early warning system and guide drug distribution.
The US FDA has issued guidance to manufacturers on impurities in finished drugs which can change human DNA and cause cancer.
update
AmpliPhi Biosciences’ phage-based antibacterial therapies plant in Ljubljana has been deemed to meet manufacturing standards by Slovenian regulators.
Inform Genomics has selected Icon as its contract research organization (CRO) for the pivotal multicenter study of its Hematopoietic Stem Cell Transplant (HSCT)/Mucositis product candidate.
The US FDA has issued a warning letter to Czech API manufacturer VUAB Pharma for failing to properly respond to microbiological contamination and data integrity issues.